Radiotherapy Market - Strategic Insights and Forecasts (2026-2031)

The radiotherapy market is set to reach USD 12.8 billion in 2031, growing at a CAGR of 6.8 % from USD 9.20 billion in 2026.

The radiotherapy market is undergoing a transformation driven by the convergence of imaging, software, and treatment delivery technologies. Modern radiotherapy solutions increasingly rely on real-time imaging and adaptive planning, enabling clinicians to adjust treatment protocols based on tumor response. This shift toward adaptive radiotherapy enhances treatment precision and improves clinical outcomes, making it a central trend shaping the market. As a result, technologies such as image-guided radiation therapy and volumetric modulated arc therapy are gaining traction across healthcare institutions.

Another significant trend is the integration of radiotherapy with systemic therapies, including chemotherapy and immunotherapy, to create multi-modal treatment approaches. This integration improves therapeutic efficacy, particularly in complex and advanced-stage cancers. Additionally, there is growing interest in hypofractionation, where higher doses of radiation are delivered over fewer sessions. This approach reduces treatment time and improves patient convenience, which is particularly valuable in high-volume healthcare settings. These trends collectively highlight the evolution of radiotherapy from a standalone treatment to a highly sophisticated and integrated component of cancer care.

Market Dynamics

Market Drivers

• Rising Global Cancer Burden: The increasing incidence of cancers such as breast, lung, and prostate cancers is a primary driver of radiotherapy demand. As more patients require treatment, radiotherapy’s effectiveness in tumour control ensures its continued adoption across diverse clinical settings, making it a cornerstone of oncology care.

• Technological Advancements in Radiotherapy Systems: Continuous innovation in radiotherapy technologies, including IMRT, IGRT, and proton therapy, significantly enhances treatment precision and safety. These advancements improve clinical outcomes and reduce side effects, which encourages adoption among healthcare providers and supports market growth.

• Growing Adoption of Precision Medicine: The shift toward personalised treatment approaches is driving the use of advanced radiotherapy techniques that can be tailored to individual patient profiles. This trend increases the effectiveness of treatment while minimising damage to healthy tissues, thereby improving patient’s quality of life.

• Expansion of Healthcare Infrastructure: Investments in healthcare infrastructure, particularly in emerging markets, are increasing access to radiotherapy services. The establishment of new cancer treatment centres and the upgrading of existing facilities are driving demand for advanced radiotherapy equipment.

Market Restraints

• High capital investment and maintenance costs associated with advanced radiotherapy equipment limit adoption in low-resource settings

• Shortage of skilled professionals required to operate complex radiotherapy systems affects treatment capacity

• Radiation exposure risks and potential side effects create concerns among patients and healthcare providers

Market Opportunities

• Adoption of Advanced Radiotherapy Technologies: The increasing demand for precision treatment creates opportunities for technologies such as proton therapy and stereotactic radiosurgery. These advanced modalities offer superior targeting capabilities, improving outcomes and expanding the market.

• Integration with Multi-Modal Treatment Approaches: Combining radiotherapy with chemotherapy and immunotherapy enhances treatment effectiveness. This integration creates opportunities for more comprehensive cancer care solutions, increasing the utilisation of radiotherapy in complex cases.

• Emerging Markets Expansion: Developing regions present significant growth opportunities due to rising cancer incidence and improving healthcare infrastructure. Investments in radiotherapy facilities in these regions are expected to drive substantial market expansion.

• Development of AI-Driven Treatment Planning: Artificial intelligence is being increasingly integrated into radiotherapy planning and delivery systems. AI-driven solutions improve accuracy, reduce planning time, and enhance workflow efficiency, creating new growth avenues for the market.

Supply Chain Analysis

The radiotherapy supply chain involves manufacturers of linear accelerators, imaging systems, and software platforms, alongside healthcare providers delivering treatment. Demand variability is increasing as advanced technologies require specialized components and high-precision manufacturing. Equipment production depends on regulatory compliance and quality assurance standards. Companies are expanding production capabilities to meet growing demand. Distribution networks are evolving to support installation and maintenance of complex systems. This supply chain requires coordination across stakeholders to ensure availability and operational reliability.

Government Regulations

Market Segmentation

By Type

Radiotherapy demand varies by modality, where external beam radiotherapy dominates due to widespread use across cancer types. Demand is shifting toward advanced subtypes such as IMRT, IGRT, and proton therapy as precision requirements increase. Conventional radiotherapy techniques limit treatment effectiveness, which drives adoption of advanced modalities. Companies are expanding product portfolios across multiple radiotherapy types. This segmentation reflects modality-driven demand shaping technology adoption.

By Application

Radiotherapy demand is highest in cancers such as breast, lung, and prostate due to established treatment protocols. Demand is increasing across other cancer types as radiotherapy applications expand. Variability in tumor location and sensitivity limits uniform treatment approaches, which necessitates application-specific strategies. Healthcare providers are tailoring radiotherapy protocols based on cancer type. This segmentation highlights disease-driven demand patterns influencing market growth.

By End User

Healthcare providers define radiotherapy demand, where hospitals and specialty cancer centers dominate due to infrastructure requirements. Demand is increasing in research institutes as innovation in radiotherapy techniques expands. High equipment costs constrain adoption in smaller facilities, which drives concentration in specialized centers. Providers are investing in advanced radiotherapy systems to meet demand. This segmentation reflects infrastructure-driven demand shaping market access.

Regional Analysis

North America Market Analysis

North America leads the radiotherapy market due to advanced healthcare infrastructure, high adoption of cutting-edge technologies, and strong investment in cancer research. The presence of leading industry players further supports innovation and market growth.

Europe Market Analysis

Europe shows steady growth driven by well-established healthcare systems and increasing adoption of advanced radiotherapy techniques. Supportive regulatory frameworks and government initiatives enhance access to treatment.

Asia Pacific Market Analysis

Asia Pacific is the fastest-growing region, supported by rising cancer incidence and expanding healthcare infrastructure. Increasing investments in radiotherapy facilities are improving access and driving market expansion.

Rest of the World

The rest of the world is experiencing gradual growth as awareness of cancer treatment increases and healthcare systems develop. Radiotherapy remains a critical modality due to its effectiveness and expanding availability.

Regulatory Landscape

The regulatory environment for radiotherapy is characterised by stringent standards governing equipment safety, radiation exposure, and clinical efficacy. Regulatory bodies ensure that radiotherapy systems meet rigorous quality and safety requirements before approval, which is essential given the potential risks associated with radiation exposure. Compliance with these standards is critical for manufacturers, as it directly impacts market entry and adoption.

In addition to equipment regulations, there is an increasing focus on software validation and cybersecurity, particularly as radiotherapy systems become more digitised and integrated with hospital networks. Regulatory agencies are also supporting innovation by providing pathways for the approval of advanced technologies such as AI-driven treatment planning systems. These efforts facilitate the introduction of new solutions while maintaining patient safety.

Ongoing monitoring and post-market surveillance are essential components of the regulatory framework. These measures ensure that radiotherapy systems continue to perform effectively and safely over time, providing valuable data for continuous improvement and innovation in the field.

Pipeline Analysis

The radiotherapy pipeline is robust, with significant investment in advanced technologies aimed at improving precision and patient outcomes. A growing number of clinical studies are focused on integrating imaging and treatment delivery systems, enabling real-time adaptive radiotherapy. This approach allows for dynamic adjustments during treatment, which enhances efficacy and reduces side effects.

Data indicates an increasing number of trials evaluating the use of proton therapy and stereotactic techniques in a wider range of cancer types. These studies aim to expand the clinical applications of high-precision radiotherapy, particularly in complex and hard-to-treat tumors. Additionally, research into AI-driven treatment planning and automation is gaining momentum, with several solutions in development designed to improve workflow efficiency and accuracy.

The pipeline also reflects a strong emphasis on combination therapies, where radiotherapy is used alongside systemic treatments to enhance overall outcomes. This trend highlights the evolving role of radiotherapy as part of integrated cancer care, ensuring its continued relevance and growth in the oncology market.

Competitive Landscape

Siemens Healthineers AG

Siemens Healthineers AG focuses on advanced imaging and integrated radiotherapy solutions, leveraging its technological expertise to enhance treatment precision and workflow efficiency.

Koninklijke Philips N.V.

Koninklijke Philips N.V. emphasizes innovation in image-guided therapy and digital health solutions, supporting improved radiotherapy planning and patient management.

Canon Medical Systems Corporation

Canon Medical Systems Corporation invests in imaging technologies that complement radiotherapy, enhancing diagnostic accuracy and treatment planning capabilities.

Brainlab AG

Brainlab AG specializes in software-driven radiotherapy solutions, including treatment planning and navigation systems that improve precision and clinical outcomes.

ViewRay

ViewRay differentiates itself through MR-guided radiotherapy systems enabling real-time tumor tracking. The company is advancing adaptive radiotherapy technologies. Its focus on precision and innovation enhances treatment effectiveness. Strategic investments support growth. This positioning strengthens its competitive advantage.

Key Developments

• January 2026: Elekta announced a strategic focus on innovation and expansion in key markets, including the U.S. and China, in 2026, which is driving the adoption of precision radiotherapy systems through targeted geographic expansion and technology development.

• January 2026: Elekta received U.S. FDA 510(k) clearance in January 2026 for its Evo CT-Linac system, which integrates AI-enhanced imaging with radiation delivery, increasing demand for precision radiotherapy platforms that enable real-time tumour visualisation and adaptive treatment planning.

• January 2025: Siemens Healthineers AG introduced a new imaging solution integrated with radiotherapy systems for enhanced precision.

• March 2026: Siemens Healthineers entered a long-term value partnership with Onvida Health in 2026 to expand access to advanced oncology technologies, which is increasing the deployment of integrated radiotherapy and imaging systems across healthcare networks.

Strategic Insights and Future Market Outlook

The radiotherapy market is poised for sustained growth, driven by technological innovation and increasing demand for precision oncology. The integration of advanced imaging, AI, and treatment delivery systems is transforming radiotherapy into a highly sophisticated and effective treatment modality. Companies are focusing on developing solutions that enhance accuracy, reduce treatment time, and improve patient outcomes, which are critical factors in maintaining competitiveness.

Future market dynamics will be shaped by the adoption of personalized treatment approaches and the expansion of radiotherapy applications across a broader range of cancers. Emerging markets will play a crucial role in driving growth, as investments in healthcare infrastructure improve access to advanced treatment options. Additionally, the continued development of combination therapies will further strengthen the role of radiotherapy in integrated cancer care.

The radiotherapy market is expected to evolve rapidly, with innovation and collaboration driving advancements in technology and clinical practice. As healthcare systems increasingly prioritize effective and efficient cancer treatment, radiotherapy will remain a central component of oncology care.

Radiotherapy continues to demonstrate its importance as a precise and adaptable cancer treatment modality, with ongoing advancements ensuring its relevance and effectiveness in addressing the growing global burden of cancer.

Radiotherapy Market Scope: